Genital Warts: Clinical Trials

40 trials for Genital Warts, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

32 completed, 3 active not recruiting, 2 unknown, 1 not yet recruiting. 16 Phase 3, 5 Phase 2, 4 Not applicable, 4 Phase 4, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 316Completed 13, Active not recruiting 2, Unknown 1
Phase 25Completed 4, Recruiting 1
Not applicable4Completed 2, Not yet recruiting 1, Unknown 1
Phase 44Completed 3, Terminated 1
Phase 12Completed 2
Early Phase 11Completed 1

Follow Genital Warts: new trials by email Literature Review of Genital Warts trials Research Report on Genital Warts

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Oral Ivermectin for Genital Warts
Ivermectin - Genital Warts
Not applicableNot yet recruitingUniversity of Health Sciences Lahore902027-02-202026-11-03
Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel
Geniwa gel, Placebo gel - HPV (Human Papillomavirus)-Associated, Genital Warts
Phase 2RecruitingKTH Biopharma702026-07-162026-10-20
A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males
Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.coli), Aluminum Adjuvant - Penile/Perineal /Perianal Intraepithelial Neoplasia, Anal Intraepithelial Neoplasia
Phase 3Active not recruitingXiamen University93002025-04-112025-07-31
Immunogenicity and Safety of V503 in Chinese Males 9 Through 19 Years Old (V503-053)
9vHPV vaccine - Genital Warts
Phase 3Active not recruitingMerck Sharp & Dohme LLC15902022-05-072023-01-19
Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Small Genital Warts
Aminolevulinic acid photodynamic therapy - Genital Warts
Not applicableUnknownShanghai Dermatology Hospital202019-05-102019-05-29
Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts
Quadrivalent HPV vaccine, Hepatitis B vaccine - Genital Warts
Phase 3CompletedUniversity of Pretoria522018-07-012026-01-23
Efficacy of Quadrivalent HPV Vaccine to Prevent Relapses of Genital Warts After Initial Therapeutic Response
Vaccination with Gardasil, Injection of Normal Saline - Genital Warts
Phase 3UnknownAssistance Publique - Hôpitaux de Paris3002017-11-152018-02-27
Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004)
V503 - Cervical Cancer, Vulvar Cancer
Phase 3CompletedMerck Sharp & Dohme LLC12122017-09-202019-11-21
Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021)
V503, GARDASIL - Cervical Cancer, Vulvar Cancer
Active not recruitingMerck Sharp & Dohme LLC44532016-01-222024-11-12
Topical NVN1000 for the Treatment of External Genital and Perianal Warts
NVN1000 8% Gel, NVN1000 16%, Vehicle - Genital Warts, Perianal Warts
Phase 2CompletedNovan, Inc.1082015-06-122023-04-06
Long Term Follow-up of HPV Vaccine in HIV (CTN 236)
Cervical Cancer, Human Papillomavirus Infection
CompletedUniversity of British Columbia2412015-06-012025-04-08
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
Simple Reminder - Human Papilloma Virus Infection Type 11, Human Papilloma Virus Infection Type 16
Not applicableCompletedRegenstrief Institute, Inc.13052015-02-012016-05-25
Efficacy and Safety Profiles of SR-T100 Gel on External Genital Warts/Condyloma Acuminate(EGWs)
Vehicle gel, SR-T100 gel with 1.0 % SM, SR-T100 gel with 2.3% SM - Condyloma Acuminata, Genital Warts
Phase 2CompletedG&E Herbal Biotechnology Co., LTD1382014-08-012020-02-05
The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases
Human Papillomavirus Infection, Genital Warts
CompletedJun Zhang46912014-06-012019-05-07
HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts
Automated Reminder, Automated Reminder Plus Script - Human Papilloma Virus Infection Type 11, Human Papilloma Virus Infection Type 16
Not applicableCompletedRegenstrief Institute, Inc.6472014-02-012016-03-11
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003)
9vHPV Vaccine - Genital Warts, Anal Cancer
Phase 3CompletedMerck Sharp & Dohme LLC25202012-10-292018-11-27
Impact of HPV Vaccination Against Cervical Lesions and Genital Warts in Colombia. an Ecological Assessment
HPV vaccine - Cervical Intraepithelial Neoplasia (CIN), Genital Warts
CompletedUniversidad Nacional de Colombia80000002012-01-012024-11-22
A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts
Oral Zinc, Placebo - Genital Warts, HPV
Phase 4TerminatedUniversity of British Columbia502011-11-012016-11-02
SR-T100 Gel Efficacy & Safety Study for Vulva Pre-cancerous Lesions & Cutaneous Condyloma
SR-T100 gel with 2.3% of SM in Solanum undatum plant extract - Vulvar Intraepithelial Neoplasia, Genital Warts
Early Phase 1CompletedNational Cheng-Kung University Hospital292011-04-012014-04-22
Typing of Human Papilloma Virus (HPV) From Female Genital Warts
Medical / Surgical Treatment - Genital Warts, Human Papilloma Virus
CompletedUniversity of Cape Town1562010-04-012013-01-24

Showing 20 of 40. Sign in to see all of them.

Narrower conditions

Condylomata Acuminata (40)  ·  Uterine Cervical Neoplasms (19)  ·  Papillomavirus Infections (11)  ·  Vaginal Neoplasms (7)  ·  Vulvar Neoplasms (7)  ·  Anus Neoplasms (2)  ·  Oropharyngeal Neoplasms (2)  ·  Recurrence (2)  ·  Uterine Cervical Dysplasia (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Warts (1)

Broader conditions

Communicable Diseases (40)  ·  DNA Virus Infections (40)  ·  Disease Attributes (40)  ·  Genital Diseases (40)  ·  Infections (40)  ·  Pathologic Processes (40)  ·  Pathological Conditions, Signs and Symptoms (40)  ·  Sexually Transmitted Diseases (40)  ·  Sexually Transmitted Diseases, Viral (40)  ·  Skin Diseases (40)  ·  Skin Diseases, Infectious (40)  ·  Skin Diseases, Viral (40)  ·  Skin and Connective Tissue Diseases (40)  ·  Tumor Virus Infections (40)  ·  Urogenital Diseases (40)

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (10)  ·  Vaccines, Synthetic (5)  ·  Papillomavirus Vaccines (3)  ·  Duration of Therapy (2)  ·  Imiquimod (2)  ·  Vaccines (2)  ·  GS-9191 (1)  ·  Gels (1)  ·  Hepatitis B Vaccines (1)  ·  Ivermectin (1)  ·  Ointments (1)  ·  Surgical Procedures, Operative (1)  ·  Vaccination (1)  ·  Zinc (1)  ·  berdazimer sodium (1)

Sponsors

Merck Sharp & Dohme LLC (14)  ·  Duke University (2)  ·  Graceway Pharmaceuticals, LLC (2)  ·  Regenstrief Institute, Inc. (2)  ·  University of British Columbia (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  G&E Herbal Biotechnology Co., LTD (1)  ·  Gilead Sciences (1)  ·  Jun Zhang (1)  ·  KTH Biopharma (1)  ·  La Fundacion para la Investigacion y el Desarrollo (1)  ·  Lisen Arnheim Dahlstrom (1)  ·  MEDA Pharma GmbH & Co. KG (1)  ·  MediGene (1)  ·  National Cheng-Kung University Hospital (1)

Countries

United States (7)  ·  China (4)  ·  Canada (3)  ·  Germany (2)  ·  Italy (2)  ·  South Africa (2)  ·  Taiwan (2)  ·  Austria (1)  ·  Belgium (1)  ·  Colombia (1)  ·  Finland (1)  ·  France (1)  ·  Pakistan (1)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Emmanuel B Walter, MD (2)  ·  Gregory D Zimet, PhD (2)  ·  Jason Wu, MD (2)  ·  Cheng-Yang Chou, M.D. (1)  ·  David Scheifele, MD (1)  ·  Deborah M Money, MD, FRCSC (1)  ·  Elsa Mondou, MD (1)  ·  Fausto Boselli, MD (1)  ·  Frank Wagner, Md, PD (1)  ·  Greta G Dreyer, MMed(O&G)PhD (1)  ·  Gustavo J. Hernandez-Suarez, MD (1)  ·  Joanne Langley, MD (1)  ·  Joyce Rico, MD (1)

Results publications

PMID 19236277, PMID 19236279, PMID 19935017, PMID 27422279, PMID 30982556, PMID 32184277, PMID 41166720, PMID 20949623, PMID 21471141, PMID 22454089, PMID 23066159, PMID 23299013, PMID 29074187, PMID 29211620, PMID 29995724, PMID 33326342, PMID 41276263, PMID 15215482, PMID 18164106, PMID 19116707, PMID 19453788, PMID 19505910, PMID 20647284, PMID 21248158, PMID 21300618, PMID 21307649, PMID 21491420, PMID 22469863, PMID 23486550, PMID 23632723, PMID 24055350, PMID 25278227, PMID 25693011, PMID 25749310, PMID 25912208, PMID 26366475, PMID 26411885, PMID 28789851, PMID 28797293, PMID 28886907, PMID 29029053, PMID 29269325, PMID 29767739, PMID 30852604, PMID 31201057, PMID 32247041, PMID 33676783, PMID 35149535, PMID 35525430

NIH funding

2004 (1)